Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a 403 Forbidden error page, with site header and footer visible, indicating access to the study record is blocked.SummaryDifference19%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study record revision was updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s documentation rather than to study data.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer revision label changed from v3.6.4 to v3.6.5, indicating a minor update to the page version.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page shows a new Revision: v3.6.4, replacing v3.6.3, indicating a minor update to the page content or its associated documents.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision tag was updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor maintenance update to the study entry rather than a content change.SummaryDifference0.0%

- Check88 days agoChange DetectedThe study record revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the ClinicalTrials.gov entry.SummaryDifference0.0%

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.